Literature DB >> 6722738

Follow-up of children with brain tumors.

F P Li, K R Winston, K Gimbrere.   

Abstract

One hundred two patients were evaluated for late effects of brain tumor in childhood by a medical record review and follow-up questionnaire. The patients had survived brain tumor for 5 to 47 years (median, 18 years). Among 30 patients who had received brain irradiation, 3 were successfully treated for second neoplasms that developed within the radiotherapy field 11, 16, and 29, years later, respectively. Moderate or severe functional deficits were present in 24 patients (24%), more commonly among those treated before 2 years of age and among those with cerebral astrocytoma. The other 78 patients (76%) had mild or no gross deficits, and all but 1 of them were attending school or were employed. Twenty-one patients in the series reported a total of 41 offspring, none of whom had cancer or mental retardation. Although markedly diverse performance levels were found among the 102 long-term survivors of childhood brain tumors, the majority had an acceptable quality of life.

Entities:  

Mesh:

Year:  1984        PMID: 6722738     DOI: 10.1002/1097-0142(19840701)54:1<135::aid-cncr2820540127>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003.

Authors:  Martin Benesch; Herwig Lackner; Petra Sovinz; Elisabeth Suppan; Wolfgang Schwinger; Hans-Georg Eder; Hans Jürgen Dornbusch; Andrea Moser; Karin Triebl-Roth; Christian Urban
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

Review 2.  Environmental risk factors for primary malignant brain tumors: a review.

Authors:  M Wrensch; M L Bondy; J Wiencke; M Yost
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

3.  Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivors.

Authors:  E Suc; C Kalifa; R Brauner; J L Habrand; M J Terrier-Lacombe; G Vassal; J Lemerle
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

4.  Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation.

Authors:  K Osato; Y Sato; T Ochiishi; A Osato; C Zhu; M Sato; J Swanpalmer; N Modjtahedi; G Kroemer; H G Kuhn; K Blomgren
Journal:  Cell Death Dis       Date:  2010-10-21       Impact factor: 8.469

5.  Scale for assessing quality of life of children survivors of cranial posterior fossa tumors.

Authors:  J Martinez-Climent; V Castel Sanchez; C Esquembre Menor; A Verdeguer Miralles; J Ferris Tortajada
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors.

Authors:  I Ayan; E Darendeliler; R Kebudi; O Barlas; N Ayan; C Bayindir; S Bahar; N Bilge
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

7.  A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning.

Authors:  Martin Benesch; Katharina Spiegl; Anita Winter; Andrea Passini; Herwig Lackner; Andrea Moser; Petra Sovinz; Wolfgang Schwinger; Christian Urban
Journal:  Childs Nerv Syst       Date:  2008-10-30       Impact factor: 1.475

8.  Physical functioning in pediatric survivors of childhood posterior fossa brain tumors.

Authors:  P Janine Piscione; Eric Bouffet; Donald J Mabbott; Iffat Shams; Abhaya V Kulkarni
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

9.  Impairments that influence physical function among survivors of childhood cancer.

Authors:  Carmen L Wilson; Prasad L Gawade; Kirsten K Ness
Journal:  Children (Basel)       Date:  2015

10.  Incidence and prognostic factors of ataxia in children with posterior fossa tumors.

Authors:  Helen Hartley; Barry Pizer; Steven Lane; Christine Sneade; Rebecca Williams; Conor Mallucci; Lisa Bunn; Ram Kumar
Journal:  Neurooncol Pract       Date:  2018-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.